The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of oncology drug shortages on patient treatment.
Daniel Jacob Becker
No relevant relationships to disclose
Sumit Talwar
No relevant relationships to disclose
Benjamin Levy
No relevant relationships to disclose
Molly Thorn
No relevant relationships to disclose
Janna Roitman
No relevant relationships to disclose
Ronald H. Blum
No relevant relationships to disclose
Louis Benjamin Harrison
No relevant relationships to disclose
Michael L. Grossbard
No relevant relationships to disclose